Chinese doctors have cured a patient of leukemia using gene therapy, a hospital in Chongqing announced on Friday.
Zhang Fang, a middle-aged woman, has been cured of leukemia after she was treated with CAR T therapy, Xinhua reported.
"The cancer cells have disappeared from her body. She is the first patient who has been completely cured of the disease using gene therapy," said professor Qian Cheng, director of the Bio-Treatment Centre of Southwest Hospital.
China has about four million leukemia patients. Most patients are treated using chemo-therapy or bone marrow transplants.
The CAR T treatment is a gene therapy using modified T cells to fight cancer cells in leukemia patients.
"The therapy is a much better option, because it can cut costs by at least 30 percent compared with bone marrow transplant, and is more likely to lead to a cure," the professor said.
Six other patients, who are receiving the gene therapy in the hospital, have shown improvement, he added.
The CAR T gene therapy is still in the clinical trial phase in China and has only been carried out in fewer than ten hospitals across the country.
Qian said his team is encouraged by the success and will further study the dose and improve the therapy.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
